Page 3 - Daily Technicals

Nifty likely to be sideways; Nocil, Alkyl Amine top tech calls for Jan 3

Nifty could now remain in the 21,770-21,477 band for the near term, a sper Vinay Rajani of HDFC Securities

Chart check: Wait for dips in Nifty FMCG; book out profits in Nifty Energy

Traders are advised to exercise patience and wait for opportune moments to capitalize on potential price dips in Nifty FMCG and its stocks, says Ravi Nathani

Nifty Financial Services, Nifty Private Bank: Avoid taking short positions

Consider booking profits on upward movements in Nifty Financial Services, suggests Ravi Nathani

Sell on Rise: Nifty FMCG and Nifty Auto ripe for profit booking

A decisive close above 16,880 is essential to trigger a renewed wave of bullish sentiment in both Nifty Auto and its constituents, said Ravi Nathani

Buy Nifty Financial near these levels to gain from a likely bullish upmove

Nifty Financial Services Index presents a bullish outlook, and traders are advised to closely monitor the resistance levels for potential breakout opportunities, said Ravi Nathani

Nifty Auto eyes fresh selling below this level; Buy Nifty IT near support

As per Ravi Nathani, traders should wait for the correction to complete and start buying Nifty IT index at or near the support level of 29,800

Buy Nifty PSU Bank at this support; Nifty FMCG strategy eyed in this range

As per Ravi Nathani, adopting a buy-low, sell-high strategy for Nifty FMCG within the established range is the most prudent course of action

Nifty Financial, Nifty Private Bank: Trading strategy for near-term decline

As per Ravi Nathani, the Nifty Private Bank index is poised to encounter a stronghold of support at 22,200, according to chart analysis.

Nifty50 index to consolidate in near-term; Buy Bank Nifty on dips: Nathani

Buy the Bank Nifty index either at the current market price of 43,600 or seize the opportunity below this threshold, says Ravi Nathani

Buy Max Financial Services October Futures, suggests HDFC Securities

RSI Oscillators is sloping upwards and placed above 50 on the daily chart, indicating strength in the stock, says Nandish Shah

Sell Nifty PSU Bank on rise; buying opportunity in Nifty FMCG at this level

According to Ravi Nathani, traders eyeing Nifty FMCG index might find value in purchasing when the index nears the lower limit of its current range

Nifty Financial, Nifty Private Bank: Wait for these breakouts for direction

According to Ravi Nathani, initiating trades before the breakout occurs is laden with risk, traders should act once the breakout signals the market's chosen direction

Nifty struggling to cross 20-DEMA; UCO Bank, Lemon Tree top technical picks

As per Vinay Rajani, Nifty's 20 DEMA is placed at 19,700 odd levels. A sustainable level above this could result in a bullish trend reversal in Nifty

TV18 Broadcast, TTML, SJVN: 5 stocks under Rs 100 that can rally up to 50%

SJVN, Tata Teleservices (Maharashtra) and TV18 Broadcast may rise 50 per cent on resilient charts

HDFC Bank, Uflex among 5 oversold stocks you should avoid accumulating

The trend among stocks in oversold regions remains highly fragile and could see more downside ahead

Centum, HAL: Chandrayaan-3 soft landing can see related stks jump up to 15%

Shares related to Chandrayaan-3 may rise up to 15 per cent in the upcoming sessions, as per their respective technical chart patterns

Escorts, GIC, Welspun: 5 stocks at 52-wk high may turn multibaggers in FY24

The trend in these stocks remains highly robust, with price action exhibiting strong interest from market participants.

VIP Ind, NBCC: 5 small-caps to accumulate despite indices staying fragile

Selective small-cap stocks may rally up to 25 per cent, as per their respective charts

FMCGs extend fall on RBI's warning of higher inflation; more pain on cards?

Barring Varun Beverages that reached a new all-time high and Colgate Palmolive (India), other FMCG stocks trade fragile.

Cipla, Glenmark: Time to accumulate pharma stocks on robust bullish trend?

The current volatility in the benchmark indices offer the ideal opportunity to accumulate pharma stocks around their respective supports